Search results
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 7 hours agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
Fact Check: Study does not say COVID vaccines may have fuelled excess deaths
Reuters· 15 hours agoA newly released study does not say COVID-19 vaccines may have fuelled excess deaths across the...
New COVID Vaccines Targeting JN.1 Will Arrive This Fall
Verywell Health via Yahoo News· 6 days agoKP.2 and KP.3, offshoots of JN.1, are now the dominant variants in circulation. If the FDA signs off...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 2 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
Texas House approves ban on COVID-19 vaccine mandates by private employers
KRGV Rio Grande Valley· 4 days agoSign up for The Brief, The Texas Tribune’s daily newsletter that keeps readers up to speed on the...
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
Yahoo Finance via AOL· 2 days agoModerna president Stephen Hoge knows investors are waiting to see the company grow in a big way and...
Aaron Rodgers’ descent into the right-wing fever swamps
Media Matters· 2 days agoWhat began publicly as a hesitancy to get vaccinated for COVID-19 appears to have devolved, with the...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 3 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
3 Reasons to Buy Moderna Stock
Motley Fool via Yahoo Finance· 6 days agoAlthough Moderna (NASDAQ: MRNA) is now a somewhat famous biotech, it was a relatively unknown, clinical-stage company just five years ago. Its success in...
Moderna's combo Covid, flu vaccine meets goals in late-stage study - Boston Business Journal
The Business Journals· 3 days agoModerna Inc. is making steady headway on its plan to launch all four products from its respiratory ...